Biotech & Life Sciences.

Responsibility depends on trial structure and contracts. Sponsors, CROs and trial sites may each carry specific insurance obligations, and misalignment can lead to uninsured exposure or regulatory non-compliance.

Risk profiles evolve significantly as products progress from research to trials, manufacturing and distribution. Insurance programs must adapt to reflect increased patient exposure, regulatory scrutiny, manufacturing risk and global product liability requirements.

Programs can be structured with worldwide jurisdiction, local regulatory compliance and cross-border coverage to support global trials, manufacturing and commercial supply.

Products Liability and Professional Indemnity insurance can respond to claims arising from injury, malfunction, contamination or failure to perform, subject to policy structure and approved use status.

Property, Business Interruption and Products Liability insurance can respond to contamination, equipment failure or supply chain disruption, helping protect revenue, regulatory standing and continuity.

Cyber incidents can compromise sensitive research data, clinical trial systems, patient records and connected medical devices. Cyber insurance helps address data breaches, ransomware, system failure and regulatory response costs.

Inadequate or non-compliant insurance can delay trials, breach contracts, invalidate approvals or expose directors and sponsors to personal liability. Early review is critical.

Intellectual Property insurance can protect against infringement claims and defence costs relating to patents, proprietary technology or licensed IP, which are often core to enterprise value.